102 related articles for article (PubMed ID: 6305680)
1. (-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function.
Zsilla G; Barbaccia ML; Gandolfi O; Knoll J; Costa E
Eur J Pharmacol; 1983 Apr; 89(1-2):111-7. PubMed ID: 6305680
[TBL] [Abstract][Full Text] [Related]
2. The (-)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals.
Gandolfi O; Barbaccia ML; Costa E
Eur J Pharmacol; 1984 Apr; 100(2):233-7. PubMed ID: 6329776
[TBL] [Abstract][Full Text] [Related]
3. On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors.
Barbaccia ML; Brunello N; Chuang DM; Costa E
Neuropharmacology; 1983 Mar; 22(3 Spec No):373-83. PubMed ID: 6304555
[TBL] [Abstract][Full Text] [Related]
4. Effects of repeated trazodone administrations on serotonergic neurotransmission: biochemical studies.
Gandolfi O; Roncada P; Dall'Olio R
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):941-52. PubMed ID: 2554363
[TBL] [Abstract][Full Text] [Related]
5. Repeated administrations of (-)-deprenyl increase [3H]MK801 binding in rat brain and antagonize the impairment of passive avoidance conditioning induced by N-methyl-D-aspartate receptor antagonists.
Gandolfi O; Dall'Olio R; Rimondini R; Bongrani S; Valsecchi B
Neurosci Lett; 1994 Jan; 165(1-2):113-6. PubMed ID: 7912412
[TBL] [Abstract][Full Text] [Related]
6. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
7. Chronic antidepressant treatment and mouse brain 3H-imipramine binding.
Severson JA; Anderson B
J Neurosci Res; 1986; 16(2):429-38. PubMed ID: 3020258
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1993 Jun; 13(3):203-15. PubMed ID: 8242685
[TBL] [Abstract][Full Text] [Related]
9. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
Gandolfi O; Barbaccia ML; Costa E
J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970
[TBL] [Abstract][Full Text] [Related]
10. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
[TBL] [Abstract][Full Text] [Related]
11. Effect of antidepressant and narcoleptic drugs on N-isopropyl p-iodoamphetamine biodistribution in animals.
Moretti JL; Holman BL; Delmon L; Carmel A; Johnson D; Moingeon P; Blau M
J Nucl Med; 1987 Mar; 28(3):354-9. PubMed ID: 3029345
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex.
Mishra R; Gillespie DD; Youdim MB; Sulser F
Psychopharmacology (Berl); 1983; 81(3):220-3. PubMed ID: 6316394
[TBL] [Abstract][Full Text] [Related]
13. [Antidepressant drugs and central monoaminergic receptors].
Asakura M; Tsukamoto T
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
[TBL] [Abstract][Full Text] [Related]
14. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.
Kinnier WJ; Chuang DM; Costa E
Eur J Pharmacol; 1980 Oct; 67(2-3):289-94. PubMed ID: 6257531
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
Timar J; Knoll B; Knoll J
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms in the action of minaprine.
Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):629-37. PubMed ID: 2851858
[TBL] [Abstract][Full Text] [Related]
18. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
Benmansour S; Brunswick DJ
Brain Res; 1994 Jul; 650(2):305-12. PubMed ID: 7953696
[TBL] [Abstract][Full Text] [Related]
19. Absence of 2-phenylethylamine binding after monoamine oxidase inhibition in rat brain.
Li XM; Juorio AV; Paterson IA; Boulton AA
Eur J Pharmacol; 1992 Jan; 210(2):189-93. PubMed ID: 1601056
[TBL] [Abstract][Full Text] [Related]
20. The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats.
Timár J; Knoll B
Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):50-60. PubMed ID: 3083795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
